This website uses cookies to enhance the user experience.
DYNATEC ENGINEERING AS

DYNATEC ENGINEERING AS915 223 818

Research
Limited company
Rakkestadveien 1 1814 ASKIM, Norge

DYNATEC ENGINEERING AS

Forside - Dynatec
DYNATEC bruker erfaring, innsikt og kunnskap for å effektivisere matindustrien. Sammen med ledende produsenter utvikler vi optimale og innovative løsninger.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
30 years
since Mar 12, 1995
Type
Limited company
VAT registered
Yes
Number of employees
7

Ownership

Number of shares and share classes
150
1 share class
Total number of shareholders
3
1 company, 2 persons
Belongs to group of

Financials

Total operating income 2023
29,192,439
NOK
Annual total result 2023
1,340,531
NOK
Total equity 2023
22,596,474
NOK
Last update: Sep 12, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
60 %
indirectly

Board

NameRoleShares
Chairman
10 %
directly
Board Member
60 %
indirectly
Board Member
30 %
directly

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Board Member
60 %
indirectly
Board Member
30 %
directly
Chairman
10 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
J
J.F. HOLDING AS
Ordinary shares
90
60 %
Ordinary shares
45
30 %
Ordinary shares
15
10 %

Shares owned by the DYNATEC ENGINEERING AS

NameShare classNumber of sharesShare
C
CENATE AS
Ordinary shares
498
2.62 %
N
NACAMED AS
Ordinary shares
26,000
1.98 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -12,652
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
29,192,439
29,786,459
33,098,779
Annual Total Result
1,340,531
-1,477,681
3,937,238
Total assets
28,601,975
26,836,531
29,265,662
Total liabilities
6,005,501
5,580,588
6,532,037
Total equity
22,596,474
21,255,943
22,733,625

P&L

Year202320222021
Total operating income
29,192,439
29,786,459
33,098,779
Total operating costs
27,889,155
32,999,941
29,467,705
Operating result
1,303,283
-3,213,482
3,631,073
Financial income/costs
356,163
78,212
45,700
Profit before tax
1,659,447
-3,135,269
3,676,773
Total tax & extraordinary income/cost
318,916
-1,657,588
-260,465
Annual Total Result
1,340,531
-1,477,681
3,937,238

Balance overview

Year202320222021
Total fixed assets
7,310,551
7,648,450
5,895,945
Total current assets
21,291,423
19,188,081
23,369,717
Total assets
28,601,975
26,836,531
29,265,662
Short term debt
6,005,501
5,580,588
6,532,037
Long term debt
0
0
0
Total liabilities
6,005,501
5,580,588
6,532,037
Contributed capital
600,000
600,000
600,000
Retained earnings
21,996,474
20,655,943
22,133,625
Total equity
22,596,474
21,255,943
22,733,625
Total equity and liabilities
28,601,975
26,836,531
29,265,662

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology